NASDAQ · BMRA

Biomerica Inc

Closing price · Nov 13, 2026 $1.36
Last insider buy price $1.60 Paid by Director David Moatazedi on Aug 26, 2026 (Form 4). Not today's price.

Latest quarter · ended Aug 31, 2026

Sales slipped and cash got weaker

descriptionFiled Oct 15, 2026
Revenue growthShrinking
−8.3%
Quarter ended Nov 30, 2024: +4.4% sales vs. a year beforeQuarter ended Feb 28, 2025: +10.0% sales vs. a year beforeQuarter ended May 31, 2025: −32.9% sales vs. a year beforeQuarter ended Aug 31, 2025: −23.6% sales vs. a year beforeQuarter ended Nov 30, 2025: −26.0% sales vs. a year beforeQuarter ended Feb 28, 2026: −11.8% sales vs. a year beforeQuarter ended May 31, 2026: +16.8% sales vs. a year beforeQuarter ended Aug 31, 2026: −8.3% sales vs. a year before
Nov '24Aug '26
$1.26M vs. $1.38M a year ago
Gross marginWorse
8.1%
Quarter ended Nov 30, 2024: 26.7% gross marginQuarter ended Feb 28, 2025: 1.7% gross marginQuarter ended May 31, 2025: -32.6% gross marginQuarter ended Aug 31, 2025: 30.7% gross marginQuarter ended Nov 30, 2025: 4.2% gross marginQuarter ended Feb 28, 2026: -4.5% gross marginQuarter ended May 31, 2026: -8.1% gross marginQuarter ended Aug 31, 2026: 8.1% gross margin
Nov '24Aug '26
vs. 30.7% a year ago
Cash from operationsWorse
−$802K
Quarter ended Nov 30, 2024: −$791K cash from operationsQuarter ended Feb 28, 2025: −$1.04M cash from operationsQuarter ended May 31, 2025: −$662K cash from operationsQuarter ended Aug 31, 2025: −$268K cash from operationsQuarter ended Nov 30, 2025: −$991K cash from operationsQuarter ended Feb 28, 2026: −$1.25M cash from operationsQuarter ended May 31, 2026: −$912K cash from operationsQuarter ended Aug 31, 2026: −$802K cash from operations
Nov '24Aug '26
vs. −$268K a year ago
Share countDiluting
+60.2%
Quarter ended Nov 30, 2024: 18.34M sharesQuarter ended Feb 28, 2025: 20.37M sharesQuarter ended May 31, 2025: 2.82M sharesQuarter ended Aug 31, 2025: 2.87M sharesQuarter ended Nov 30, 2025: 3.02M sharesQuarter ended Feb 28, 2026: 3.09M sharesQuarter ended May 31, 2026: 4.59M sharesQuarter ended Aug 31, 2026: 4.6M shares
Nov '24Aug '26
4.6M shares vs. 2.87M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 +100
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

21 funds report owning BMRA, up from 11

Holdings as of Jun 30, 2026
New10
Added1
Held8
Trimmed2
Sold out0

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Dec 12 · 30,000 shStock grant · Dec 12 · 62,500 sh · 3 peopleStock grant · Dec 12 · 52,500 shStock grant · Dec 12 · 40,000 shOpen-market buy · Aug 20 · $50KOpen-market buy · Aug 26 · $32KOpen-market buy · Aug 26 · $26K · 2 peopleOpen-market buy · Aug 26 · $50K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOpen-market buy · Aug 20 · $50KOpen-market buy · Aug 26 · $32KOpen-market buy · Aug 26 · $26K · 2 peopleOpen-market buy · Aug 26 · $50K

Last 6 months. A wider screen shows 12.

Showing 5 real trades. Hidden: 6 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Aug 26 Zackary Irani CEO, Director Open-market buy $50K 31,250 sh at $1.60
Aug 26 Allen Barbieri Executive Vice Chairman, Director Open-market buy $32K 20,000 sh at $1.60
Aug 26 David Moatazedi Director Open-market buy $16K 10,000 sh at $1.60
Aug 26 Eric Chin Director Open-market buy $10K 6,250 sh at $1.60
Aug 20 M. Gary Director Open-market buy $50K 31,250 sh at $1.60

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in BMRA

As of Jun 30, 2026
FundOwnsValueChange
HRT Financial LP0.6%$46KNew
Geode Capital Management, LLC0.5%$42.9K−57%
BlackRock, Inc.0.4%$32.8KSame
Vanguard Capital Management LLC0.3%$25.5KSame
Jane Street Group, LLC0.3%$22.2KNew

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist